Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monserrat

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 6, 2020
Development and validation of a next-generation sequencing panel for clinical pharmacogeneticsLuis Ramudo-Cela, Jesús María López-Martí, Daniel Colmeiro-Echeberría, et al.
Revista Espanola De Cardiologia (English Ed.)|March 21, 2020
Identification by next-generation sequencing of 2 novel cases of noncompaction cardiomyopathy associated with 1p36 deletionsMaría Luisa Peña-Peña, Juan Pablo Trujillo-Quintero, Dolores García-Medina, et al.
Current Pharmaceutical Design|December 9, 2014
Genetics of cardiomyopathies: novel perspectives with next generation sequencingLorenzo Monserrat, Martin Ortiz-Genga, Ivan Lesende, et al.
The American Journal of Cardiology|May 12, 2007
Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathyCarlos Alberto Dumont, Lorenzo Monserrat, Jesús Peteiro, et al.
Revista Espanola De Cardiologia|July 13, 2002
[Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy]Lorenzo Monserrat, Manuel Hermida, Beatriz Bouzas, et al.
Revista Espanola De Cardiologia|May 2, 2009
A homozygous MYBPC3 gene mutation associated with a severe phenotype and a high risk of sudden death in a family with hypertrophic cardiomyopathyMartín F Ortiz, María Isabel Rodríguez-García, Manuel Hermida-Prieto, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 3, 2007
Left ventricular asynchrony in patients with hypertrophic cardiomyopathy: its determinants and its relation to left ventricular functionCarlos A Dumont, Lorenzo Monserrat, Rafaela Soler, et al.
Revista Espanola De Cardiologia|August 27, 2010
Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathyRoberto Barriales-Villa, Raúl Centurión-Inda, Xusto Fernández-Fernández, et al.
Molecular Genetics and Metabolism|May 23, 2018
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of expertsMarco Spada, Ralf Baron, Perry M Elliott, et al.
Revista Espanola De Cardiologia|September 18, 2004
[Real time myocardial contrast echocardiography to predict left ventricular wall motion recovery after reperfused acute myocardial infarction]Jesús Peteiro, Rafaela Soler, Lorenzo Monserrat, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 6, 2020
Development and validation of a next-generation sequencing panel for clinical pharmacogeneticsLuis Ramudo-Cela, Jesús María López-Martí, Daniel Colmeiro-Echeberría, et al.
Revista Espanola De Cardiologia (English Ed.)|March 21, 2020
Identification by next-generation sequencing of 2 novel cases of noncompaction cardiomyopathy associated with 1p36 deletionsMaría Luisa Peña-Peña, Juan Pablo Trujillo-Quintero, Dolores García-Medina, et al.
Current Pharmaceutical Design|December 9, 2014
Genetics of cardiomyopathies: novel perspectives with next generation sequencingLorenzo Monserrat, Martin Ortiz-Genga, Ivan Lesende, et al.
The American Journal of Cardiology|May 12, 2007
Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathyCarlos Alberto Dumont, Lorenzo Monserrat, Jesús Peteiro, et al.
Revista Espanola De Cardiologia|July 13, 2002
[Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy]Lorenzo Monserrat, Manuel Hermida, Beatriz Bouzas, et al.
Revista Espanola De Cardiologia|May 2, 2009
A homozygous MYBPC3 gene mutation associated with a severe phenotype and a high risk of sudden death in a family with hypertrophic cardiomyopathyMartín F Ortiz, María Isabel Rodríguez-García, Manuel Hermida-Prieto, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 3, 2007
Left ventricular asynchrony in patients with hypertrophic cardiomyopathy: its determinants and its relation to left ventricular functionCarlos A Dumont, Lorenzo Monserrat, Rafaela Soler, et al.
Revista Espanola De Cardiologia|August 27, 2010
Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathyRoberto Barriales-Villa, Raúl Centurión-Inda, Xusto Fernández-Fernández, et al.
Molecular Genetics and Metabolism|May 23, 2018
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of expertsMarco Spada, Ralf Baron, Perry M Elliott, et al.
Revista Espanola De Cardiologia|September 18, 2004
[Real time myocardial contrast echocardiography to predict left ventricular wall motion recovery after reperfused acute myocardial infarction]Jesús Peteiro, Rafaela Soler, Lorenzo Monserrat, et al.
Pageof 16